Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-048607
Filing Date
2025-04-01
Accepted
2025-04-01 16:36:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A crbp_defa14a_2025_04_01.htm DEFA14A 13699
2 GRAPHIC img192851997_0.jpg GRAPHIC 104034
3 GRAPHIC img192851997_1.jpg GRAPHIC 62929
  Complete submission text file 0000950170-25-048607.txt   245010
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37348 | Film No.: 25800330
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)